Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,329,516
-$1,518,769 QoQ
Shares Held
21,245
-33.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#332
of 1,603 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $4,379,567,692 across 14 Drug Manufacturers - General names. NVS ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,190,792 | $1,428,271,766 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,484,756 | $833,291,145 | |
| 3 | JNJ |
Johnson & Johnson
|
3,255,567 | $826,816,350 | |
| 4 | ABBV |
AbbVie Inc.
|
2,374,888 | $597,616,815 | |
| 5 | AZN |
Astrazeneca PLC
|
1,233,595 | $233,914,282 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,845,511 | $233,161,858 | |
| 7 | AMGN |
Amgen Inc
|
195,409 | $70,761,506 | |
| 8 | BIIB |
Biogen Inc.
|
246,782 | $53,319,718 |
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,329,516 | 21,245 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,848,285 | 31,740 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,790,046 | 27,490 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $4,268,468 | 33,285 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $5,230,657 | 43,225 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,376,704 | 39,260 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $3,772,708 | 38,770 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $6,261,113 | 54,435 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $5,188,328 | 48,735 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $1,643,926 | 16,995 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $2,770,111 | 27,435 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $2,794,529 | 27,435 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $2,768,465 | 27,435 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $904,820 | 9,835 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $1,529,085 | 16,855 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $1,281,148 | 16,855 | Shares | Defined | 2025-02-07 | |
| 2020-09-30 | $54,266,864 | 624,044 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $55,767,549 | 638,511 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $61,602,434 | 747,149 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||